Sampaio, E P <br/><br/>
Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL).  [electronic resource] 

 -  Clinical and experimental immunology  Feb 1998 
 - 300-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0009-9104 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2249.1998.00510.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Cells, Cultured<br/>Erythema Nodosum--drug therapy<br/>Female<br/>Gene Expression--drug effects<br/>Humans<br/>Leprosy, Lepromatous--drug therapy<br/>Male<br/>Middle Aged<br/>Pentoxifylline--therapeutic use<br/>Phosphodiesterase Inhibitors--therapeutic use<br/>Polymerase Chain Reaction<br/>RNA, Messenger--metabolism<br/>Tumor Necrosis Factor-alpha--biosynthesis